Literature DB >> 15926615

[The metabolic syndrome: effects of a pronounced weight loss induced by bariatric surgery].

Julia Engl1, Ursula Hanusch-Enserer, Rudolf Prager, Josef R Patsch, Christoph Ebenbichler.   

Abstract

The prevalence of obesity is rising worldwide dramatically, affecting up to 50 percent of the population. The epidemic of obesity leads to a marked increase in the metabolic syndrome, a cluster of cardiovascular risk factors characterized by visceral obesity, insulin resistance, low HDL-Cholesterol, hypertriglyceridemia, and a subclinical proinflammatory state. In the last years, the NCEP and the WHO highlighted and defined the key features of the metabolic syndrome to facilitate the clinical diagnosis and preventive interventions. The conservative therapy of obesity and the metabolic syndrome by life style intervention and pharmacological interventions leads only to moderate weight loss with inconstant long-term success. Intervention by bariatric surgery can serve as a model for the metabolic effects of permanent weight loss. In several studies the pronounced weight loss induced a reduction of almost all components of the metabolic syndrome, including glucose and lipid status and is followed by an improvement in the quality of life. Recent research suggested a decrease in mortality rate in addition to cost effectiveness of bariatric surgery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15926615     DOI: 10.1007/s00508-005-0346-7

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  7 in total

Review 1.  [Antipsychotic drug-induced changes in metabolism].

Authors:  Julia Engl; Alexander Tschoner; Markus Laimer; Maria Rettenbacher; W Wolfgang Fleischhacker; Josef R Patsch; Christoph Ebenbichler
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

2.  [Epidemiologic "paradox"--Why do 'obese' patients have a better prognosis?].

Authors:  Wilfred Druml
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

3.  Public health aspects of diabetes mellitus--epidemiology, prevention strategies, policy implications: the first Austrian diabetes report.

Authors:  Thomas Dorner; Theres Rathmanner; Monika Lechleitner; Robert Schlögel; Michael Roden; Kitty Lawrence; Franz Schwarz; Ingrid Kiefer; Michael Kunze; Anita Rieder
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

4.  Improvement of glycemic control after a 3-5 day insulin infusion in type 2-diabetic patients with insulin resistance can be maintained with glitazone therapy.

Authors:  Georg Biesenbach; Peter Grafinger; Andreas Raml
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

5.  Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery.

Authors:  Ursula Hanusch-Enserer; Mohammed A Ghatei; Edmund Cauza; Steven R Bloom; Rudolf Prager; Michael Roden
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  [Steatohepatitis and cirrhosis: first manifestation 23 years after jejunoileal bypass surgery].

Authors:  Peter Piringer; Robert Buder; Fritz Firlinger; Christine Kapral; Christian Luft; Wolfgang Sega; Friedrich Wewalka; Kurt Lenz
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

7.  Gender-specific effect of metabolic syndrome on rate adjusted QT interval in middle-aged participants of an atherosclerosis prevention program.

Authors:  Bernhard Strohmer; Christiana Schernthaner; Bernhard Iglseder; Bernhard Paulweber; Maximilian Pichler
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.